×

Pharmaceutical composition for treatment of Duchenne muscular dystrophy

  • US 20020055481A1
  • Filed: 08/16/2001
  • Published: 05/09/2002
  • Est. Priority Date: 08/25/2000
  • Status: Active Grant
First Claim
Patent Images

1. An isolated and purified oligonucleotide selected from the group consisting of a DNA comprising the nucleotide sequence set forth as SEQ ID NO:

  • 15 in the Sequence Listing and an RNA comprising the nucleotide sequence complementary to the nucleotide sequence that in turn is complementary to the nucleotide sequence set forth as SEQ ID NO;

    15 in the Sequence Listing.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×